根据 位华尔街分析师的预测,Yubo International Biotech Ltd 的收入预期范围从 $ 到 $
Yubo International Biotech Ltd 的盈利质量评分是多少?
Yubo International Biotech Ltd 的盈利质量评分为 B+/54.022205。该评分基于盈利能力、增长、现金生成与资本分配以及杠杆四个维度。
Yubo International Biotech Ltd 何时发布财报?
Yubo International Biotech Ltd 的下一份财报预计在 发布
Yubo International Biotech Ltd 的预期收益是多少?
根据华尔街分析师的预测,Yubo International Biotech Ltd 的预期收益为 $
Yubo International Biotech Ltd 是否超出收益预期?
Yubo International Biotech Ltd 最近的收益为 $, 预期。
关键数据
前收盘价
$0.0151
开盘价
$0.0104
当日区间
$0.0104 - $0.0151
52周范围
$0.0079 - $0.1776
交易量
10.0K
平均成交量
3.5K
股息收益率
--
每股收益(TTM)
-0.01
市值
$2.5M
什么是 YBGJ?
Yubo International Biotech Ltd. engages in the supply of products that process, store, and administer therapeutic doses of endometrial stem cells for the treatment of disease and injuries. The company is headquartered in Beijing, Beijing and currently employs 18 full-time employees. The firm focuses on the research and development and application of endometrial stem cells and offers its products and services under the brand VIVCELL. The Company’s product offerings include healthcare products for respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products. The firm also offers stem cell related services including cell testing and health management consulting services.